328 related articles for article (PubMed ID: 1438278)
1. The monoclonal CD4 antibody M-T413 inhibits cellular infection with human immunodeficiency virus after viral attachment to the cell membrane: an approach to postexposure prophylaxis.
Rieber EP; Federle C; Reiter C; Krauss S; Gürtler L; Eberle J; Deinhardt F; Riethmüller G
Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10792-6. PubMed ID: 1438278
[TBL] [Abstract][Full Text] [Related]
2. CD4 immunoadhesin, but not recombinant soluble CD4, blocks syncytium formation by human immunodeficiency virus type 2-infected lymphoid cells.
Sekigawa I; Chamow SM; Groopman JE; Byrn RA
J Virol; 1990 Oct; 64(10):5194-8. PubMed ID: 2398542
[TBL] [Abstract][Full Text] [Related]
3. Contact of human immunodeficiency virus type 1-infected and uninfected CD4+ T lymphocytes is highly cytolytic for both cells.
Heinkelein M; Sopper S; Jassoy C
J Virol; 1995 Nov; 69(11):6925-31. PubMed ID: 7474110
[TBL] [Abstract][Full Text] [Related]
4. A monoclonal antibody to the gp120-CD4 complex has differential effect on HIV-induced syncytium formation and viral infectivity.
Konopka K; Pretzer E; Celada F; Düzgüneş N
J Gen Virol; 1995 Mar; 76 ( Pt 3)():669-79. PubMed ID: 7897355
[TBL] [Abstract][Full Text] [Related]
5. Rat monoclonal antibodies to nonoverlapping epitopes of human immunodeficiency virus type 1 gp120 block CD4 binding in vitro.
Cordell J; Moore JP; Dean CJ; Klasse PJ; Weiss RA; McKeating JA
Virology; 1991 Nov; 185(1):72-9. PubMed ID: 1718090
[TBL] [Abstract][Full Text] [Related]
6. Full-length CD4 electroinserted in the erythrocyte membrane as a long-lived inhibitor of infection by human immunodeficiency virus.
Zeira M; Tosi PF; Mouneimne Y; Lazarte J; Sneed L; Volsky DJ; Nicolau C
Proc Natl Acad Sci U S A; 1991 May; 88(10):4409-13. PubMed ID: 2034680
[TBL] [Abstract][Full Text] [Related]
7. Synergistic inhibition of HIV-1 envelope-mediated cell fusion by CD4-based molecules in combination with antibodies to gp120 or gp41.
Allaway GP; Ryder AM; Beaudry GA; Maddon PJ
AIDS Res Hum Retroviruses; 1993 Jul; 9(7):581-7. PubMed ID: 8369162
[TBL] [Abstract][Full Text] [Related]
8. Expression and characterization of cM-T413, a chimeric anti-CD4 antibody with in vitro immunosuppressive activity.
Looney JE; Willinger A; Lin G; Rieber EP; Riethmuller G; Ghrayeb J
J Immunother Emphasis Tumor Immunol; 1994 Jul; 16(1):36-46. PubMed ID: 8081558
[TBL] [Abstract][Full Text] [Related]
9. A monoclonal antibody to CD4 domain 2 blocks soluble CD4-induced conformational changes in the envelope glycoproteins of human immunodeficiency virus type 1 (HIV-1) and HIV-1 infection of CD4+ cells.
Moore JP; Sattentau QJ; Klasse PJ; Burkly LC
J Virol; 1992 Aug; 66(8):4784-93. PubMed ID: 1378510
[TBL] [Abstract][Full Text] [Related]
10. Another discontinuous epitope on glycoprotein gp120 that is important in human immunodeficiency virus type 1 neutralization is identified by a monoclonal antibody.
Ho DD; Fung MS; Cao YZ; Li XL; Sun C; Chang TW; Sun NC
Proc Natl Acad Sci U S A; 1991 Oct; 88(20):8949-52. PubMed ID: 1717992
[TBL] [Abstract][Full Text] [Related]
11. Infection of monocytes by human immunodeficiency virus type 1 blocked by inhibitors of CD4-gp120 binding, even in the presence of enhancing antibodies.
Perno CF; Baseler MW; Broder S; Yarchoan R
J Exp Med; 1990 Apr; 171(4):1043-56. PubMed ID: 2324685
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human monoclonal antibody IgG1b12 neutralizes diverse human immunodeficiency virus type 1 primary isolates.
Kessler JA; McKenna PM; Emini EA; Chan CP; Patel MD; Gupta SK; Mark GE; Barbas CF; Burton DR; Conley AJ
AIDS Res Hum Retroviruses; 1997 May; 13(7):575-82. PubMed ID: 9135875
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human immunodeficiency virus (HIV) infection in vitro by anticarbohydrate monoclonal antibodies: peripheral glycosylation of HIV envelope glycoprotein gp120 may be a target for virus neutralization.
Hansen JE; Clausen H; Nielsen C; Teglbjaerg LS; Hansen LL; Nielsen CM; Dabelsteen E; Mathiesen L; Hakomori SI; Nielsen JO
J Virol; 1990 Jun; 64(6):2833-40. PubMed ID: 1692349
[TBL] [Abstract][Full Text] [Related]
14. Phorbol ester-induced down modulation of tailless CD4 receptors requires prior binding of gp120 and suggests a role for accessory molecules.
Golding H; Dimitrov DS; Manischewitz J; Broder CC; Robinson J; Fabian S; Littman DR; Lapham CK
J Virol; 1995 Oct; 69(10):6140-8. PubMed ID: 7545243
[TBL] [Abstract][Full Text] [Related]
15. Broadly neutralizing antibodies targeted to mucin-type carbohydrate epitopes of human immunodeficiency virus.
Hansen JE; Nielsen C; Arendrup M; Olofsson S; Mathiesen L; Nielsen JO; Clausen H
J Virol; 1991 Dec; 65(12):6461-7. PubMed ID: 1719230
[TBL] [Abstract][Full Text] [Related]
16. Antibody raised against soluble CD4-rgp120 complex recognizes the CD4 moiety and blocks membrane fusion without inhibiting CD4-gp120 binding.
Celada F; Cambiaggi C; Maccari J; Burastero S; Gregory T; Patzer E; Porter J; McDanal C; Matthews T
J Exp Med; 1990 Oct; 172(4):1143-50. PubMed ID: 2212945
[TBL] [Abstract][Full Text] [Related]
17. A human recombinant Fab identifies a human immunodeficiency virus type 1-induced conformational change in cell surface-expressed CD4.
Bachelder RE; Bilancieri J; Lin W; Letvin NL
J Virol; 1995 Sep; 69(9):5734-42. PubMed ID: 7637018
[TBL] [Abstract][Full Text] [Related]
18. Active immunity against the CD4 receptor by using an antibody antigenized with residues 41-55 of the first extracellular domain.
Lanza P; Billetta R; Antonenko S; Zanetti M
Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11683-7. PubMed ID: 8265609
[TBL] [Abstract][Full Text] [Related]
19. Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120.
Hart TK; Kirsh R; Ellens H; Sweet RW; Lambert DM; Petteway SR; Leary J; Bugelski PJ
Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2189-93. PubMed ID: 2006155
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of human immunodeficiency virus type 1 envelope-mediated fusion by a CD4-gp120 complex-specific monoclonal antibody.
Lee S; Peden K; Dimitrov DS; Broder CC; Manischewitz J; Denisova G; Gershoni JM; Golding H
J Virol; 1997 Aug; 71(8):6037-43. PubMed ID: 9223495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
